US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (255)
  • Diseases & Conditions (3949)
  • Drug Delivery (279)
  • Therapeutic Area (7131)
  • Vaccines (720)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024
9/6/2014 | published by: Visiongain
... of kinase inhibitors? Now get the latest analysis for those cancer treatments. There you explore developments, other trends, results, opportunities and revenue forecasts. Visiongain’s new report shows you what’s possible for drugs using protein kinase ...  |  read more...
USD 2,986
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines
8/1/2014 | published by: Kelly Scientific Publications
... Biosimilars, Generics & Vaccines” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises top Indian pharmacos and their battle ...  |  read more...
USD 2,000
Latest Guidebook for Conducting Pharma Clinical Trials - China: From Regulations to Practice (2014 Edition)
7/25/2014 | published by: Access China Management Consulting Ltd.
... of the largest healthcare markets around the world. Along with sustained economic and population growth as well as an ageing population, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. ...  |  read more...
USD 1,495
Health Supplement Stores
7/21/2014 | published by: First Research, Inc.
... based in the US). Worldwide, vitamins and dietary supplements generate about $85 billion in annual sales from all channels, according to Euromonitor. The US is the world's largest market and China is the fastest-growing. Growth ...  |  read more...
USD 129
Kidney Dialysis Centers
7/21/2014 | published by: First Research, Inc.
... Braun Melsungen. The US commercial kidney dialysis industry includes about 4,200 centers with combined annual revenue of about $16 billion. COMPETITIVE LANDSCAPE Demand depends on the number of people who suffer from kidney disease. The ...  |  read more...
USD 129
Pharmaceuticals and Healthcare Report Q3 2014 - Ghana
7/16/2014 | published by: Business Monitor International
... remain positive for the sectorwith the government's focus on domestic pharmaceutical sector, greater foreign pharmaceutical companyinterest in the country and capacity building initiatives for bringing global quality control standards toGhanaian pharmaceutical industry will spur domestic ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Moldova
7/16/2014 | published by: Business Monitor International
... with the EU inJune 2014, which would strengthen the business environment and improve the regulatory structure andaccess to the pharmaceutical market in the country. Moldova is undertaking a reform of its healthcaresector with the World ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Spain
7/16/2014 | published by: Business Monitor International
... to drugmakers operating in the country. Despite calls made by companies for theimplementation of a system that adequately rewards innovation and supports investment in futuremedicines, the government is likely to remain committed to fiscal consolidation ...  |  read more...
USD 1,295
Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)
7/16/2014 | published by: Frost & Sullivan
... the year 2018 with a CAGR of ??%. The total global parenteral finished products market is estimated to be worth $??billion. Parenteral finished products include vials with sterile liquids or powders to be reconstituted for ...  |  read more...
USD 3,000
Pharmaceuticals and Healthcare Report Q3 2014 - Greece
7/16/2014 | published by: Business Monitor International
... will continue to target the pharmaceutical and healthcare industry to reduce public spending.We highlight, however, that the generic drug sector and private healthcare industry will present somegrowth opportunities in the country. Headline Expenditure Projections Pharmaceuticals: ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Lithuania
7/16/2014 | published by: Business Monitor International
... The upcoming switch to theeuro promises to boost purchasing power and stabilise the pharmaceutical market, albeit at the cost ofincreasing healthcare expenditure. Ceding control of monetary policy to Brussels leaves Lithuania withlittle leeway to increase ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Slovakia
7/16/2014 | published by: Business Monitor International
... agencyTASR. The government added that after adding contributions from the state budget, the total funds that havebeen allocated for developing healthcare infrastructure will be EUR300mn (USD417.3mn). The governmentplans to allocate these funds to projects in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Serbia
7/16/2014 | published by: Business Monitor International
... reduce itsdebt burden. However, pharmaceutical spending is also a target for cuts. Local drug makers are set to feelthe worst of these new measures as they cannot compete on cost compared to larger players in ...  |  read more...
USD 1,295
Leukemia Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... projects in cancer. In addition, there are 5 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 127 drugs. Leukemia Drug Pipeline Update lists all drugs and gives ...  |  read more...
USD 6,746
Arbovax, Inc. - Product Pipeline Review - 2014
7/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Arbovax, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Mucosis B.V. - Product Pipeline Review - 2014
7/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Mucosis B.V.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... several hallmarks of cancer such as cell growth and proliferation, angiogenesis, and bioenergetics. Since mTOR acts as a neoplastic switch that is frequently turned on by many mutations found in cancer, inhibition of mTOR may ...  |  read more...
USD 6,746
NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... more than 20 members in mammals and plays a pivotal role in the recognition of intracellular ligands. There are today 87 companies plus partners developing 75 NOD-like receptor signaling pathway targeting drugs in 239 developmental ...  |  read more...
USD 4,496
Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... three successful drugs are just the top of an emerging line of therapy. Given the fact that they all target tyrosine kinases and that kinase mutations can cause patients to become resistant to these drugs, ...  |  read more...
USD 6,746
IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 28 drugs. Il-9 Signaling Pathway In Oncology Drug Pipeline Update ...  |  read more...
USD 4,496
Euroscreen S.A. - Product Pipeline Review - 2014
7/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Euroscreen S.A.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Malignant Mesothelioma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
... therapeutic development for Malignant Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cirrhosis - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
... Cirrhosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Batten Disease - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
... therapeutic development for Batten Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Radiation Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... 725 developmental projects in cancer. In addition, there are 7 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 140 drugs. Radiation Therapy In Oncology Drug Pipeline Update ...  |  read more...
USD 6,746
< prev 1    3  4  5  6  7  8  9  10  
 
Our Clients